Literature DB >> 27466385

Rapid Bedside Inactivation of Ebola Virus for Safe Nucleic Acid Tests.

Maiken Worsøe Rosenstierne1, Helen Karlberg2, Karoline Bragstad3, Gunnel Lindegren2, Malin Lundahl Stoltz2, Cristiano Salata4, Anne-Marte Bakken Kran5, Susanne Gjeruldsen Dudman3, Ali Mirazimi6, Anders Fomsgaard7.   

Abstract

Rapid bedside inactivation of Ebola virus would be a solution for the safety of medical and technical staff, risk containment, sample transport, and high-throughput or rapid diagnostic testing during an outbreak. We show that the commercially available Magna Pure lysis/binding buffer used for nucleic acid extraction inactivates Ebola virus. A rapid bedside inactivation method for nucleic acid tests is obtained by simply adding Magna Pure lysis/binding buffer directly into vacuum blood collection EDTA tubes using a thin needle and syringe prior to sampling. The ready-to-use inactivation vacuum tubes are stable for more than 4 months, and Ebola virus RNA is preserved in the Magna Pure lysis/binding buffer for at least 5 weeks independent of the storage temperature. We also show that Ebola virus RNA can be manually extracted from Magna Pure lysis/binding buffer-inactivated samples using the QIAamp viral RNA minikit. We present an easy and convenient method for bedside inactivation using available blood collection vacuum tubes and reagents. We propose to use this simple method for fast, safe, and easy bedside inactivation of Ebola virus for safe transport and routine nucleic acid detection.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27466385      PMCID: PMC5035422          DOI: 10.1128/JCM.00346-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Virus inactivation by nucleic acid extraction reagents.

Authors:  Jamie A Blow; David J Dohm; Diane L Negley; Christopher N Mores
Journal:  J Virol Methods       Date:  2004-08       Impact factor: 2.014

2.  Virus inactivation by solvent/detergent treatment using Triton X-100 in a high purity factor VIII.

Authors:  Peter L Roberts
Journal:  Biologicals       Date:  2008-09       Impact factor: 1.856

3.  Evaluation of Ebola virus inactivation procedures for Plasmodium falciparum malaria diagnostics.

Authors:  Rachel Lau; Amanda Wang; Ann Chong-Kit; Filip Ralevski; Andrea K Boggild
Journal:  J Clin Microbiol       Date:  2015-01-28       Impact factor: 5.948

4.  Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation.

Authors:  L H Elliott; J B McCormick; K M Johnson
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

5.  Sensitivity to ultraviolet radiation of Lassa, vaccinia, and Ebola viruses dried on surfaces.

Authors:  Jose-Luis Sagripanti; C David Lytle
Journal:  Arch Virol       Date:  2010-11-23       Impact factor: 2.574

6.  Rapid detection protocol for filoviruses.

Authors:  Manfred Weidmann; Elke Mühlberger; Frank T Hufert
Journal:  J Clin Virol       Date:  2004-05       Impact factor: 3.168

7.  Rapid detection of filoviruses by real-time TaqMan polymerase chain reaction assays.

Authors:  Yi Huang; Hongping Wei; Yunpeng Wang; Zhengli Shi; Herve Raoul; Zhiming Yuan
Journal:  Virol Sin       Date:  2012-09-21       Impact factor: 4.327

8.  Inactivation of Ebola virus with a surfactant nanoemulsion.

Authors:  A A Chepurnov; L F Bakulina; A A Dadaeva; E N Ustinova; T S Chepurnova; J R Baker
Journal:  Acta Trop       Date:  2003-08       Impact factor: 3.112

9.  Ebola virus inactivation with preservation of antigenic and structural integrity by a photoinducible alkylating agent.

Authors:  Kelly L Warfield; Dana L Swenson; Gene G Olinger; Warren V Kalina; Mathias Viard; Mohamed Aitichou; Xiaoli Chi; Sofi Ibrahim; Robert Blumenthal; Yossef Raviv; Sina Bavari; M Javad Aman
Journal:  J Infect Dis       Date:  2007-11-15       Impact factor: 5.226

10.  Quantitative analysis of particles, genomes and infectious particles in supernatants of haemorrhagic fever virus cell cultures.

Authors:  Manfred Weidmann; Amadou A Sall; Jean-Claude Manuguerra; Lamine Koivogui; Aime Adjami; Faye Fatou Traoré; Kjell-Olof Hedlund; Gunnel Lindegren; Ali Mirazimi
Journal:  Virol J       Date:  2011-02-24       Impact factor: 4.099

View more
  6 in total

1.  Rapid, Safe, and Simple Manual Bedside Nucleic Acid Extraction for the Detection of Virus in Whole Blood Samples.

Authors:  Maiken W Rosenstierne; Christopher E Jensen; Anders Fomsgaard
Journal:  J Vis Exp       Date:  2018-06-30       Impact factor: 1.355

2.  Assessment of hepatitis B virus pregenomic RNA in high and low viremic chronic hepatitis B patients.

Authors:  Aymen Farid Elshayeb; Mohamed Gamal Abdrabu; Sara Lotfy Asar; Mohamed Adel Abdelaziz; Hossam Abuelkheir
Journal:  Clin Exp Hepatol       Date:  2021-03-25

3.  Use of guanidine thiocyanate-based nucleic acid extraction buffers to inactivate poliovirus in potentially infectious materials.

Authors:  Michelle J Honeywood; Stacey Jeffries-Miles; Kimberly Wong; Chelsea Harrington; Cara C Burns; M Steven Oberste; Michael D Bowen; Everardo Vega
Journal:  J Virol Methods       Date:  2021-08-09       Impact factor: 2.623

4.  Effective chemical virus inactivation of patient serum compatible with accurate serodiagnosis of infections.

Authors:  M M Remy; M Alfter; M-N Chiem; M T Barbani; O B Engler; F Suter-Riniker
Journal:  Clin Microbiol Infect       Date:  2018-10-28       Impact factor: 8.067

5.  Species-specific quantification of circulating ebolavirus burden using VP40-derived peptide variants.

Authors:  Qingbo Shu; Tara Kenny; Jia Fan; Christopher J Lyon; Lisa H Cazares; Tony Y Hu
Journal:  PLoS Pathog       Date:  2021-11-08       Impact factor: 6.823

Review 6.  Methods of Inactivation of Highly Pathogenic Viruses for Molecular, Serology or Vaccine Development Purposes.

Authors:  Simon Elveborg; Vanessa M Monteil; Ali Mirazimi
Journal:  Pathogens       Date:  2022-02-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.